announces ABM Respiratory Care THE BIWAZE CLEAR SYSTEM GOT FDA APPROVAL

37 0

The BiWaze® Clear System has received FDA 510(k) clearance, according to ABM Respiratory Care, a medical technology business dedicated to creating and expanding the global market for revolutionary integrated airway clearance and breathing solutions. By employing Oscillating Lung Expansion (OLE) therapy, this novel airway clearance technology assists patients in clearing their airways and preventing or treating atelectasis. In the hospital, long-term care facility, and home situations, BiWaze® Clear can be used to treat both acute and chronic respiratory problems. When someone has a respiratory ailment such cystic fibrosis, bronchiectasis, or neuromuscular problems, OLE therapy is used to help remove secretions from the airways. It has been used in hospitals for more than a decade and is a successful airway clearance therapy. OLE medication was shown to reduce postoperative pulmonary problems by 31% and shorten the mean hospital stay by 1.6 days in a recent trial involving post-surgical patients 1.
The portable, battery-powered BiWaze® Clear system is a cutting-edge invention that can be utilised anywhere. With the help of a special Dual Lumen Breathing CircuitTM, it administers OLE treatment. This circuit prevents inhaled aerosol from escaping the handset or breathing tube until it has been filtered by a coaxial bacterial/viral filter. Lung expansion, high frequency oscillation, and nebulization using the Aerogen® Solo are the three therapies provided by BiWaze® Clear.

Source: Prnewswire

No Comments

Leave a Comment

Your email address will not be published. Required fields are marked *